Jubilant Life Sciences Q3 net up 80 percent to Rs 212.84 crore Ruby Khatun Khatun18 Jan 2018 10:45 AM ISTNew Delhi: Drug firm Jubilant Life Sciences reported an 80.20 percent rise in its consolidated net profit to Rs 212.84 crore for the third quarter...
JB Chemicals and Pharma's Gujarat facilities get European nod Ruby Khatun Khatun18 Jan 2018 10:30 AM ISTNew Delhi: JB Chemicals and Pharmaceuticals said the Medicines Authority of Malta has granted European GMP approval to its manufacturing facilities...
Tata Trusts launches Impact Lab for public health Ruby Khatun Khatun18 Jan 2018 10:15 AM ISTNew Delhi: Tata Trusts said it has set up an 'Impact Lab' at IIT Delhi in partnership with health innovation player PATH for healthcare solutions in...
US court invalidates patent on Johnson and Johnson cancer drug Zytiga Ruby Khatun Khatun18 Jan 2018 10:00 AM ISTNEW YORK: A U.S. administrative court on Wednesday invalidated a Johnson and Johnson patent on its blockbuster prostate cancer drug Zytiga, bringing...
UK drugs regulator plays down Brexit disruption threat Ruby Khatun Khatun18 Jan 2018 9:30 AM ISTLONDON: Britain’s drugs regulator said on Tuesday it would work to minimise disruption caused by the country leaving the European Union as it tried to...
Patanjali ties up with Amazon, Flipkart, 1mg, Netmeds, Paytm Mall to push ayurveda products Ruby Khatun Khatun17 Jan 2018 11:00 AM ISTNew Delhi: Baba Ramdev-led Patanjali Ayurved announced its partnership with eight online platforms in a move to push sales of its range of...
A 300 billion dollars reason to keep drugs cheap in India: Report Ruby Khatun Khatun17 Jan 2018 10:45 AM ISTGlobal pharmaceutical companies have bemoaned for years India's capricious policies on prices and patents. Now the government needs billions of...
GSK Consumer Healthcare appoints Filippo Lanzi as APAC head Ruby Khatun Khatun17 Jan 2018 10:30 AM ISTNew Delhi: GSK Consumer Healthcare said it has appointed Filippo Lanzi as Regional Head of Asia Pacific region.He replaces Zubair Ahmed who takes over...
FDA to speed review of medical products for use by military Ruby Khatun Khatun17 Jan 2018 9:45 AM ISTThe U.S. Food and Drug Administration (FDA) and Department of Defense launched a program on Tuesday to speed the development and review of medical...
Drugmaker Dermapharm gears up for likely first German IPO of 2018 Ruby Khatun Khatun17 Jan 2018 9:30 AM ISTFRANKFURT: German drugmaker Dermapharm is preparing for an initial public offering (IPO), probably stealing a march on much larger Siemens’ healthcare...
Lupin forays into OTC segment, eyes Rs 300 crore turnover in 5 years Ruby Khatun Khatun16 Jan 2018 11:30 AM ISTNew Delhi: Drug major Lupin said it has forayed into over-the-counter (OTC) segment in the country with plans to touch Rs 300 crore turnover in the...
Glenmark gets nod for phase II study of novel molecule Ruby Khatun Khatun16 Jan 2018 11:00 AM ISTNew Delhi: Glenmark Pharmaceuticals said it has received nod from Directorate General of Health Services, Central Drugs Standard Control Organisation,...
